Essais liés7clinical trials
VilleKogarahlocalisation
PaysAustralialocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT06544616

Ouvrir le site du centre

Essais cliniques associés

7
MoléculeIndication / populationPhaseNCTTitreStatut
JNJ-64042056 Alzheimer Phase 2 NCT06544616 Reτain — A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease ACTIVE_NOT_RECRUITING
Trontinemab Alzheimer Phase 3 NCT07170150 TRONTIER 2 — A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease RECRUITING
Prasinezumab Parkinson Phase 3 NCT07174310 PARAISO — A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease RECRUITING
XEN1101 Épilepsie Phase 3 NCT05667142 X-ACKT — A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures RECRUITING
XEN1101 Épilepsie Phase 3 NCT05718817 X-TOLE4 — An Open-label Study of XEN1101 in Epilepsy ENROLLING_BY_INVITATION
LY3439539 Alzheimer Phase 1 NCT07598370 A Study of LY3439539 in Participants With Alzheimer's Disease RECRUITING
CVN424 75 mg Parkinson Phase 3 NCT06553027 To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications ACTIVE_NOT_RECRUITING